Acro Biomedical Past Earnings Performance
Past criteria checks 0/6
Acro Biomedical's earnings have been declining at an average annual rate of -76.1%, while the Healthcare industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 58.7% per year.
Key information
-76.1%
Earnings growth rate
-71.3%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -58.7% |
| Return on equity | -4,459.2% |
| Net Margin | -4,207.2% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Acro Biomedical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 0 | -15 | 6 | 9 |
| 31 Mar 23 | 0 | -16 | 6 | 10 |
| 31 Dec 22 | 1 | -16 | 6 | 10 |
| 30 Sep 22 | 1 | -16 | 6 | 10 |
| 30 Jun 22 | 1 | -15 | 5 | 10 |
| 31 Mar 22 | 1 | -12 | 4 | 8 |
| 31 Dec 21 | 1 | -8 | 3 | 5 |
| 30 Sep 21 | 1 | -4 | 1 | 3 |
| 30 Jun 21 | 1 | -1 | 0 | 1 |
| 31 Mar 21 | 0 | 0 | 0 | 0 |
| 31 Dec 20 | 1 | 0 | 0 | 0 |
| 30 Sep 20 | 1 | 0 | 0 | 0 |
| 30 Jun 20 | 1 | 0 | 0 | 0 |
| 31 Mar 20 | 1 | 0 | 0 | 0 |
| 31 Dec 19 | 0 | 0 | 0 | 0 |
| 30 Sep 19 | 1 | 0 | 1 | 0 |
| 30 Jun 19 | 4 | 0 | 1 | 0 |
| 31 Mar 19 | 6 | 0 | 1 | 0 |
| 31 Dec 18 | 8 | 0 | 0 | 0 |
| 30 Sep 18 | 8 | 0 | 0 | 0 |
| 30 Jun 18 | 6 | 0 | 0 | 0 |
| 31 Mar 18 | 4 | 0 | 0 | 0 |
| 31 Dec 17 | 2 | 0 | 0 | 0 |
| 30 Sep 17 | 1 | 0 | 0 | 0 |
| 30 Jun 17 | 0 | 0 | 0 | 0 |
| 31 Mar 17 | 0 | 0 | 0 | 0 |
| 31 Dec 16 | 0 | 0 | 0 | 0 |
| 30 Sep 16 | 0 | 0 | 0 | 0 |
| 30 Jun 16 | 0 | 0 | 0 | 0 |
| 31 Mar 16 | 0 | 0 | 0 | 0 |
| 31 Dec 15 | 0 | 0 | 0 | 0 |
Quality Earnings: ACBM is currently unprofitable.
Growing Profit Margin: ACBM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ACBM is unprofitable, and losses have increased over the past 5 years at a rate of 76.1% per year.
Accelerating Growth: Unable to compare ACBM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ACBM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-2.5%).
Return on Equity
High ROE: ACBM has a negative Return on Equity (-4459.2%), as it is currently unprofitable.